Clinical Trials Logo

Clinical Trial Summary

This study is conducted to : Correlate the incidence of ETD with nasal polypi. To evaluate the effects of functional endoscopic sinus surgery on eustachian tube function in patients with nasal polypi


Clinical Trial Description

Eustachian tube dysfunction (ETD) is a frequently applied diagnosis, used when abnormal ET function is believed to underlie any of a wide range of symptoms or middle ear (ME) abnormalities. Two distinct forms of the disorder are recognised, representing different ends of the spectrum of ET function: 1)obstructive ETD (OETD), in which tubal opening or patency is reduced, and 2) patulous ETD (PETD), in which the ET is too open. It has been suggested that some patients with OETD have either predominantly active dysfunction (failure of muscle-controlled opening), or passive dysfunction (failure of pressure-related opening). There are several explanations to account for the ET dysfunction associated with nasal diseases: - Mechanical obstruction of ET orifice may occur due to nasal mass. - Increased secretions from seromucous glands in the pharyngeal portion of ET may accumulate and block the tube. - Lymphatic stasis due to edema of the submucosa of the tube resulting in compromise of the lumen may produce ET dysfunction. - Further increase in hydrostatic pressure result in the accumulation of ME fluid by transudative process. - Tubal dysfunction may be related to deficiency of surfactant that is thought to facilitate tubal opening. It has been postulated that this material is inactivated by inflammation. ETD symptoms will decrease post-endoscopic sinus surgery to a level comparable with a non-CRS population The use of the ETDQ-7 has the potential to enhance clinical care by highlighting the impact of ETD as well as guiding and evaluating appropriate management. Further prospective testing of ;


Study Design


Related Conditions & MeSH terms

  • Functional Endoscopic Sinus Surgery

NCT number NCT05053906
Study type Observational
Source Assiut University
Contact Safia Sh Abd-Ellattef, 3
Phone 01033111172
Email safeyasaleh21@gmail.com
Status Not yet recruiting
Phase
Start date November 1, 2021
Completion date May 1, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04105946 - Opioid Free Anesthesia in ENT Surgery N/A
Completed NCT05604599 - Intranasal Versus Intravenous Dexmedetomidine for Hypotensive Anesthesia in FESS Phase 4
Recruiting NCT05595083 - Intranasal vs. IV Dexmedetomidine in Endoscopic Sinus Surgery N/A
Recruiting NCT05442931 - Comparison Between Pregabalin and Magnesium Sulfate in Hypotensive Anaesthesia Phase 1/Phase 2
Recruiting NCT04319913 - ANI-guided Intraoperative Analgesia in Low-pressure Anesthesia N/A
Completed NCT05738135 - Aminophylline on Recovery in Functional Endoscopic Sinus Surgery Under Dexmedetomidine Hypotensive Anesthesia N/A
Recruiting NCT05828199 - The Effect of Intraoperative Infusion of Dexmedetomidine Versus Low Dose Ketamine Phase 1